Naproxen sodium, 98%
Naproxen sodium, 98%
Naproxen sodium, 98%
Thermo Scientific Chemicals

Naproxen sodium, 98%

Naproxen sodium (CAS # 26159-34-2) is an arylacetic acid of the non-steroidal anti-inflammatory drug class. | CAS: 26159-34-2 | C14H13NaO3 | 252.25 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
5 g
25 g
100 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number J63103.06
also known as J63103-06
Price (USD)
82.40
Each
Quantity:
5 g
Request bulk or custom format
Price (USD)
82.40
Each
Chemical Identifiers
CAS26159-34-2
SpecificationsSpecification SheetSpecification Sheet
Assay (special)Free Naproxen: 1.0%
Loss on Drying≤ 1.0%
Appearance (Color)White to pale cream
Assay (unspecified)≥ 90 %
Heavy Metals≤ 0.002 %
View more
A cyclooxygenase inhibitorNaproxen sodium acts as a nonselective inhibitor of Cox-1 and Cox-2. It serves as an anti-inflammatory agent with analgesic and antipyretic properties.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

  • Naproxen sodium is the sodium salt of naproxen
  • Naproxen sodium competitively suppresses prostaglandin formation and pyrogen release by blocking the conversion of arachidonic acid

Application

  • It is suitable for cell culture research.
RUO – Research Use Only

General References:

  1. K Patwardhan, S.; J Patil, M.; Anbazhagan, S. Piper Betle: A Promising Tool for Drug Permeation Enhancement of Naproxen Sodium Transdermal Gel Formulation. Curr Drug ther 2015, 10 (1), 35-43.
  2. Ünlüer, Ö. B.; Genç, L.; Kahyaoğlu, Ş. G.; Ersöz, A. Controlled Release of Naproxen Sodium from Supermacroporous Cryogels. J. Pharm. Pharmacol. 2014, 2, 527-533.